Updates are available Correction dated 2024-11-05
Click to view Correction: https://doi.org/10.1038/s41433-024-03421-6
-
Authors
Corbett, Dean
Black, Daniel
Roberts, Timothy V.
Cronin, Brendan https://orcid.org/0000-0002-4443-8915
Gunn, David https://orcid.org/0000-0001-8056-927X
Bala, Chandra
Versace, Patrick
Tsai, Linda
Papadatou, Eleni
Alarcon, Aixa https://orcid.org/0000-0002-6288-0141
Vilupuru, Srividhya https://orcid.org/0009-0006-2011-0807
-
Funding
Funding for this research was provided by:
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
Johnson & Johnson Surgical Vision, Inc.
- License Information
-
More Information
Article History
Received: 19 January 2024
Revised: 12 March 2024
Accepted: 15 March 2024
First Online: 5 April 2024
Change Date: 21 October 2024
Change Type: Update
Change Details: The original online version of this article was revised. The second sentence in the section ‘SUBJECTS/METHODS’ of the Abstract has been corrected from: “Subjects were bilaterally implanted with the EDF test (Model ZEN00V, <i>N</i> = 60) or an enhanced monofocal control (Model ICB00, <i>N</i> = 57) IOL” to: “Subjects were bilaterally implanted with the EDF test (Model ZEN00V, TECNIS PureSee™ IOL, <i>N</i> = 60) or an enhanced monofocal control (Model ICB00, TECNIS Eyhance™ IOL, <i>N</i> = 57) IOL”.
Change Date: 5 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41433-024-03421-6
Competing interests
: DC: None. DB: Consultant to, and performs research supported by, Johnson & Johnson Surgical Vision, Inc. CB: Consultant to, and performs research supported by, Johnson & Johnson Surgical Vision, Inc. and Alcon. TVR: Received investigator grants from J&J Vision and Alcon, and participated on advisory boards for Alcon, J&J Vision, Glaukos and Hoya. BC: Received consulting fees from Glaukos, Allergan, and J&J Vision. DG: Received consulting fees from Alcon and participated on paid advisory boards and as a speaker for Alcon. PV: Received clinical trial funding from J&J Vision, paid medical advisor for Teleon, Germany, participated on paid advisory boards for J&J Vision, and received speaker fees from STAAR Surgical. LT, EP, AA, and SV: Employees of Johnson & Johnson Surgical Vision, Inc.
